Citizens JMP lowered the firm’s price target on Caesars (CZR) to $43 from $45 and keeps an Outperform rating on the shares. Caesars’ EBITAR was 1% below consensus, but brings up some fears around certain areas of the business, the analyst tells investors in a research note. The bright spot was digital, highlighting improving growth, generating $80M of EBITDA in the quarter, the firm says.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CZR:
